2-amino-3-carboxymuconate-6-semialdehyde decarboxylase(English)
- an enzyme limits de novo synthesis of NAD+. As possible therapeutic target in Parkinson’s disease
- GWAS, PD, NAD+
- Enzymes, Parkinson
- https://doi.org…3233/JPD-171240
- https://doi.org…srev.00029.2022